Exposed“Accenture operates in more than 200 cities across 52 countries and relies heavily on delivery capabilities in India and the Philippines, its largest and second-largest employee populations.”
Latest 10-KFY2026Mixed ·
AI-readiness programs supported demand as managed services outgrew consulting; lower optimization costs drove much of the margin gain.
Revenue$74.2BYoY +6.5%
Net income$8.4BYoY +9.0%
Latest 10-QQ3 FY2026Positive ·
Clients prioritize cost cuts, lifting Managed Services ahead of Consulting even as its bookings decline.
Revenue$18.7BYoY +5.6%
Net income$2.3BYoY +6.4%
Latest 8-KPositiveNew guidanceEarnings ·
Plans ≈$8B in FY27 acquisitions as acquired businesses’ revenue contribution is expected to rise
Latest 8-KDebt financing ·
Debt offering closed through Accenture Capital, with floating- and fixed-rate notes fully guaranteed by Accenture plc.
Latest 8-KPositiveBuyback ·
Boosts FY2026 buybacks by $2B to $7.5B, citing a share price that fails to reflect financial strength and long-term growth opportunity.
Exposed“The business is concentrated in California and Texas, exposing it to state-specific regulation and economic conditions, California wildfires and earthquakes, and Texas hurricanes and severe weather.”
Latest S-1/Aamended IPO prospectusCustomer concentrationControlled companyProceeds to insiders or debt ·
California homeowners-insurance underwriter earns commissions; offering proceeds go entirely to existing holders
Exposed“All U.S. testing is conducted at the Brisbane, California laboratory, with no redundant facility; it is near earthquake fault lines and has no earthquake insurance.”
Latest 10-KFY2025Mixed ·
Pharmacy and Ottr expansion drive growth beyond testing, while reimbursement and collection adjustments limit revenue per test.
Revenue$379.8MYoY +13.8%
Net income−$21.4Mvs $52.5M year ago
Latest 10-QQ3 FY2026Positive ·
Naveris adds NavDx oncology testing as lab products exit; accelerating transplant demand and older-test revenue recognition fuel growth.
Revenue$139.4MYoY +39.3%
Net income$19.3Mvs $1.7M year ago
Latest 8-KPositiveEarningsGuidance raised ·
Testing Services growth, including NavDx oncology, fuels higher FY2026 revenue guidance of $520M–$530M.
Latest 8-KPositiveDeal completed ·
Sold Lab Products to Eurobio for $171.7M and acquired Naveris for $161.8M upfront, adding NavDx specialty oncology testing.
Latest 8-KExecutive payShareholder vote ·
Stockholders approved adding 1.6M shares to the 2024 Equity Incentive Plan reserve.
Exposed“Geographic concentrations—including California, New York, Florida, Illinois, and Texas—heighten exposure to local downturns, natural disasters, and insurance availability or affordability.”
Latest 10-KFY2025Mixed ·
HomeXpress added mortgage origination as Agency MBS holdings grew, increasing leverage and reliance on short-term funding.
Net interest income$266.4MYoY +0.7%
Net income$230.5MYoY +30.9%
Latest 10-QQ3 FY2026Negative ·
Mortgage valuation losses eroded capital; funding, hedging and loan-sale pricing pressures pushed HomeXpress into a loss.
Net interest income$71.2MYoY +9.5%
Net income−$172.2Mvs −$580.0K year ago
Latest 8-KDividend ·
Q4 preferred dividends of $0.50–$0.6343/share declared for Dec. 30 payment; Series B, C and D payouts are tied to three-month CME Term SOFR.
Latest 8-KNegativeEarnings ·
Higher rates and wider mortgage-credit spreads cut book value/share 16.5% Q/Q; $291M HomeXpress-backed Prism securitization launched the platform post-quarter.
Latest 8-KShareholder voteLeadership change ·
Shareholders elected Kevin G. Chavers, Gerard Creagh and Susan Mills through 2029 and approved the advisory executive-pay vote.
Latest 8-KPositiveInvestor update ·
HomeXpress origination growth and expanding third-party loan management support a hybrid model combining mortgage investment income with fee revenue.
Exposed“U.S. and Canadian operations accounted for 86% of FY2026 net sales and 83% of operating income; California alone generated 26% of U.S. net sales, and its warehouses generally have higher volumes than those in other domestic markets.”
Latest 10-KFY2026Positive ·
Executive membership upgrades and the U.S./Canada fee increase supported earnings; warehouse expansion is accelerating.
Revenue$303.2BYoY +10.1%
Net income$9.2BYoY +13.9%
Latest 10-QQ3 FY2026Positive ·
Gasoline-price inflation lifted reported sales and diluted merchandise margins, while underlying comparable-sales growth slowed.
Revenue$70.5BYoY +11.6%
Net income$2.2BYoY +15.2%
Latest 8-KPositiveBuybackLeadership change ·
Declares a $30/share special dividend and renews a $4B buyback authorization through November 2030.
Latest 8-KExecutive pay ·
Approved FY2027 executive bonus criteria tie the CEO’s $1.2M base bonus to sales, pre-tax income and environmental and social goals.
Latest 8-KDividend ·
Quarterly cash dividend of $1.47/share declared, payable Nov. 13 to shareholders of record Oct. 30.
Latest 8-KPositiveEarnings ·
IEEPA tariff refunds added $0.15 to Q4 diluted EPS, with part reinvested in member value.
Latest 8-KPositiveEarningsNew guidance ·
Higher traffic and tickets drove comparable-sales growth as gross margin narrowed; warehouse expansion targets 940 locations by FY2026 year-end.
Latest 8-KShareholder vote ·
Shareholders rejected a greenwashing-risk audit proposal; a quarterly cash dividend was declared.
Exposed“GBC’s traditional community banking business is concentrated in the Atlanta metropolitan area and serves many small and medium-sized businesses.”
Latest 8-KNegativeEarningsImpairment / charge ·
Loan and deposit interest lifted net interest income 8.0% Q/Q after the Tandem merger; subordinated-debt refinancing squeezed margins.
Latest 424B4final IPO prospectusPositiveProceeds to insiders or debt ·
Atlanta business and household lender registers up to 63.2% of expected outstanding shares for resale via direct listing
Exposed“HCA’s 103 hospitals in Texas and Florida generated 58% of Q3 admissions and 51% of revenue; those states accounted for 73% of uninsured admissions.”
Latest 10-QQ3 FY2026Negative ·
Expired enhanced Exchange tax credits and fewer Medicaid conversions swelled uninsured admissions, raising uncompensated-care costs as patient volumes grew.
Revenue$19.8BYoY +3.6%
Net income$1.6BYoY −3.9%
Latest 8-KDebt financing ·
Completed a $6.5B senior notes offering through HCA Inc., backed by HCA Healthcare’s senior unsecured guarantee.
Latest 8-KPositiveEarningsGuidance raised ·
Exchange coverage losses drove a ≈$400M pretax headwind; better admission growth and costs support an upper-half FY2026 outlook.
Exposed“At June 30, 2026, lending was concentrated in residential mortgages and commercial real estate, with much of the company’s business tied to Massachusetts and nearby markets.”
Latest S-1/Aamended IPO prospectus ·
New England lender TruNorth Bank targets a $600M midpoint conversion raise as commercial property credit worsens.
Exposed“MIHN-held operations accounted for $22.1B, or 75.2%, of 9M revenue and $26.1B, or 97.8%, of consolidated net assets of $26.7B, indicating substantial operating and asset concentration.”
Latest 10-QQ3 FY2026 ·
Derivative valuation gains drove the profit surge; lower input costs lifted adjusted operating profit, but North America weakened.
Exposed“Most loans are secured by real estate in the South Coast of Massachusetts and Rhode Island, leaving credit quality and loan demand sensitive to local economic and property conditions.”
Latest S-1/Aamended IPO prospectusMixedCEO/CFO changeControlled company ·
Massachusetts–Rhode Island community lender BayCoast Bank goes public with its mutual parent retaining 55% voting control.
Exposed“North America generated approximately 76% of total net revenues in fiscal 2026, leaving consolidated results particularly dependent on that segment and the U.S.; weakness elsewhere may not offset a North American slowdown.”
Latest 10-KFY2026PositiveRestructuring ·
Green Apron Service expands as traffic recovers; Boyu's China deal shifts stores to licensing, lowering reported revenue and lifting margins
Back to Starbucks targets ≈250 underperforming North America stores for closure, triggering ≈$300M in charges and lowering FY2026 global opening plans.
Latest 8-KLeadership change ·
Val Bauduin takes over as principal accounting officer from CFO Cathy Smith, who remains principal financial officer.
Latest 8-KDebt financing ·
Cash tender offers completed for five Starbucks note series, with accepted debt purchased and cancelled.
Latest 8-KDeal completedContract / partnership ·
Boyu Capital JV closing shifts Starbucks’ China coffeehouses toward licensed operations to support disciplined expansion.
Latest 8-KShareholder voteGovernance change ·
Shareholders approved a proposal to replace supermajority voting requirements with majority voting.